Pfizer’s cancer cachexia drug shows positive midstage trial resultsBy FinMar NewsSeptember 15, 2024Pfizer’s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the…
